302
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Prevalence and Structure of Periodontal Disease and Oral Cavity Condition in Patients with Coronary Heart Disease (Prospective Cohort Study)

, , &
Pages 8573-8581 | Published online: 23 Nov 2021

References

  • Carrizales-Sepúlveda EF, Ordaz-Farías A, Vera-Pineda R, Flores-Ramírez R. Periodontal disease, systemic inflammation and the risk of cardiovascular disease. Heart Lung Circ. 2018;27:1327–1334. doi:10.1016/j.hlc.2018.05.102
  • Zou Z, Cini K, Dong B, et al. Time trends in cardiovascular disease mortality across the BRICS: an age-period-cohort analysis of key nations with emerging economies using the global burden of disease study 2017. Circulation. 2020;141(10):790–799. doi:10.1161/CIRCULATIONAHA.119.042864
  • Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics’2017 update: a report from the American Heart Association. Circulation. 2017;135(10):146–603.
  • Dietrich T, Webb I, Stenhouse L, et al. Evidence summary: the relationship between oral and cardiovascular disease. Br Dent J. 2017;222(5):381–385. doi:10.1038/sj.bdj.2017.224
  • Andersson C, Vasan RS. Epidemiology of cardiovascular disease in young individuals. Nat Rev Cardiol. 2017;15(4):230–240. doi:10.1038/nrcardio.2017.154
  • Beck JD, Philips K, Moss K, et al. Periodontal disease classifications and incident coronary heart disease in the atherosclerosis risk in communities study. J Periodontol. 2020;91(11):1409–1418. doi:10.1002/JPER.19-0723
  • Menotti A, Puddu PE, Kromhout D, Kafatos A, Tolonen H. Coronary heart disease mortality trends during 50 years as explained by risk factor changes: the European cohorts of the Seven Countries Study. Eur J Prev Cardiol. 2019;27(9):988–998. doi:10.1177/2047487318821250
  • Khukhlina OS, Kuzminska OB, Antoniv AA, Kopchuk TH, Melnychuk SP. The cytokeratin 18, adiponectin and leptin levels in patients with non-alcoholic steatohepatitis and coronary heart disease. Arch Balk Med Union. 2019;54(3):461–466. doi:10.31688/ABMU.2019.54.3.09
  • Sanz M, Marco Del Castillo A, Jepsen S, et al. Periodontitis and cardiovascular diseases: consensus report. J Clin Periodontol. 2020;47(3):268–288. doi:10.1111/jcpe.13189
  • Batty GD, Jung KJ, Mok Y, et al. Oral health and later coronary heart disease: cohort study of one million people. Eur J Prev Cardiol. 2018;25(6):598–605. doi:10.1177/2047487318759112
  • Nazir MA. Prevalence of periodontal disease, its association with systemic diseases and prevention. Int J Health Sci. 2017;11(2):72–80.
  • Ferreira MC, Dias-Pereira AC, Branco-de-almeida LS, Martins CC, Paiva SM. Impact of periodontal disease on quality of life: a systematic review. J Periodontal Res. 2017;52(4):651–665. doi:10.1111/jre.12436
  • De Iuliis V, Ursi S, Di Tommaso LM, et al. Comparative molecular analysis of bacterial species associated with periodontal disease. J Biol Regul Homeost Agents. 2016;30(4):1209–1215.
  • Liccardo D, Cannavo A, Spagnuolo G, et al. Periodontal disease: a risk factor for diabetes and cardiovascular disease. Int J Mol Sci. 2019;20(6):1414. doi:10.3390/ijms20061414
  • Lourenço TG, Heller D, Silva-Boghossian CM, Cotton SL, Paster BJ, Colombo AP. Microbial signature profiles of periodontally healthy and diseased patients. J Clin Periodontol. 2014;41(11):1027–1036. doi:10.1111/jcpe.12302
  • Hajishengallis G. Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response. Trends Immunol. 2014;35(1):3–11. doi:10.1016/j.it.2013.09.001
  • Franco C, Patricia HR, Timo S, Claudia B, Marcela H. Matrix metalloproteinases as regulators of periodontal inflammation. Int J Mol Sci. 2017;18(2):440. doi:10.3390/ijms18020440
  • Isola G, Polizzi A, Alibrandi A, Williams RC, Lo Giudice A. Analysis of galectin-3 levels as a source of coronary heart disease risk during periodontitis. J Periodontal Res. 2021;56(3):597–605. doi:10.1111/jre.12860
  • Currò M, Matarese G, Isola G, et al. Differential expression of transglutaminase genes in patients with chronic periodontitis. Oral Dis. 2014;20(6):616–623. doi:10.1111/odi.12180
  • Isola G, Polizzi A, Santonocito S, et al. Periodontitis activates the NLRP3 inflammasome in serum and saliva. J Periodontol. 2021. doi:10.1002/JPER.21-0049
  • Isola G, Alibrandi A, Currò M, et al. Evaluation of salivary and serum ADMA levels in patients with periodontal and cardiovascular disease as subclinical marker of cardiovascular risk. J Periodontol. 2020;91:1076–1084. doi:10.1002/JPER.19-0446
  • Schenkein HA, Papapanou PN, Genco R, Sanz M. Mechanisms underlying the association between periodontitis and atherosclerotic disease. Periodontol. 2020;83:90–106. doi:10.1111/prd.12304
  • Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2019;41(1):111–188.
  • Mathews MJ, Mathews EH, Mathews GE. Oral health and coronary heart disease. BMC Oral Health. 2016;16(1):122. doi:10.1186/s12903-016-0316-7
  • Naderi S, Merchant AT. the association between periodontitis and cardiovascular disease: an update. Curr Atheroscler Rep. 2020;22(10):52. doi:10.1007/s11883-020-00878-0
  • Fujitani T, Aoyama N, Hirata F, Minabe M. Association between periodontitis and vascular endothelial function using noninvasive medical device - a pilot study. Clin Exp Dent Res. 2020;6(5):576–582. doi:10.1002/cre2.312
  • Shee F, Pralhad S, Natarajan S, et al. Cellular and biochemical changes in different categories of periodontitis: a patient-based study. J Int Soc Prev Community Dent. 2020;10(3):341–349. doi:10.4103/jispcd.JISPCD_42_20
  • Egorova SN, Bulygina IV, Vorobeva NV, Chuvashova DP, Mustafina NR. Modern Approaches to the technology of tablet dosage forms of thioctic acid (review). Drug Dev & Regist. 2021;10(2):32–41. doi:10.33380/2305-2066-2021-10-2-32-41
  • Cai QW, Ren L, Chen RX, Zou Y, Fu Q, Ma YY. Association between periodontal disease and coronary heart disease risk in Chinese population: evidence from a meta-analysis. Preprint. 2019.
  • Orlova AA, Strugar J, Shtark OY, Zhukov VA, Luzhanin VG, Povydysh MN. Use of metabolomic approaches in analysis of medicinal plants and phytopreparations (review). Drug Dev & Regist. 2021;10(1):97–105. doi:10.33380/2305-2066-2021-10-1-97-105